Among patients taking SOF+Peg-IFN+RBV, flu-like symptoms and neutropenia, well-known side-effects of Peg-IFN; were found in a minority of patients, furthermore, they were mild and did not lead to discontinuation of treatment in any of the study population. This evidence concerns the gene IFNA1 and neutropenia.